European heart journal, 43(39), 3925-3946. Oxford University Press Kronenberg, F, Mora, S, Stroes, E S G, Ference, B A, Arsenault, B J, Berglund, L, Dweck, M R, Koschinsky, M, Lambert, G, Mach, F, McNeal, C J, Moriarty, P M, Natarajan, P, Nordestgaard, B G, Parhofer, K G, Virani, S S, von Eckardstein, A, Watts, G F, Stock, J K, Ray, K K, Tokgözoğlu, L S & Catapano, A L 2022, ' Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis : a European Atherosclerosis Society consensus statement ', European Heart Journal, vol. 43, no. 39, pp. 3925-3946 . https://doi.org/10.1093/eurheartj/ehac361
European Heart Journal European Heart Journal, 2021, pp.ehab551. ⟨10.1093/eurheartj/ehab551⟩ European Heart Journal, Oxford University Press (OUP): Policy B, 2021, pp.ehab551. ⟨10.1093/eurheartj/ehab551⟩ European Heart Journal 42 (2021) 47 European Heart Journal, 42(47), 4791-4806 Ginsberg, H N, Packard, C J, Chapman, M J, Borén, J, Aguilar-Salinas, C A, Averna, M, Ference, B A, Gaudet, D, Hegele, R A, Kersten, S, Lewis, G F, Lichtenstein, A H, Moulin, P, Nordestgaard, B G, Remaley, A T, Staels, B, Stroes, E S G, Taskinen, M-R, Tokgözoğlu, L S, Tybjaerg-Hansen, A, Stock, J K & Catapano, A L 2021, ' Triglyceride-rich lipoproteins and their remnants : Metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society ', European Heart Journal, vol. 42, no. 47, pp. 4791-4806 . https://doi.org/10.1093/eurheartj/ehab551
Fruchart, J-C, Santos, R D, Aguilar-Salinas, C, Aikawa, M, Al Rasadi, K, Amarenco, P, Barter, P J, Ceska, R, Corsini, A, Després, J-P, Duriez, P, Eckel, R H, Ezhov, M V, Farnier, M, Ginsberg, H N, Hermans, M P, Ishibashi, S, Karpe, F, Kodama, T, Koenig, W, Krempf, M, Lim, S, Lorenzatti, A J, McPherson, R, Nuñez-Cortes, J M, Nordestgaard, B G, Ogawa, H, Packard, C J, Plutzky, J, Ponte-Negretti, C I, Pradhan, A, Ray, K K, Reiner, Ž, Ridker, P M, Ruscica, M, Sadikot, S, Shimano, H, Sritara, P, Stock, J K, Su, T-C, Susekov, A V, Tartar, A, Taskinen, M-R, Tenenbaum, A, Tokgözoğlu, L S, Tomlinson, B, Tybjærg-Hansen, A, Valensi, P, Vrablík, M, Wahli, W, Watts, G F, Yamashita, S, Yokote, K, Zambon, A & Libby, P 2019, ' The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm : conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation ', Cardiovascular Diabetology, vol. 18, 71 . https://doi.org/10.1186/s12933-019-0864-7